Champions Oncology, Inc. (CSBR) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Champions Oncology, Inc. (CSBR) closed at USD 4.81 on 2026-10-14, a change of -29.3 % over the past year, with a market capitalization of USD 66.67M.

Champions Oncology, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Champions Oncology, Inc. key figures

Previous close

USD 4.81 (2026-10-14)

1-year change

-29.3 %

Market cap

USD 66.67M

Enterprise value

USD 73.85M

P/E ratio (trailing)

-68.43

P/E ratio (forward)

47.90

EPS (trailing)

-0.07

EPS (forward)

0.10

PEG ratio

n/a

Price to book

17.11

Revenue growth

8.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.95

Employees

214

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Champions Oncology, Inc.

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Champions Oncology, Inc. and compare it with other stocks.